TREM1 and ventilator-associated pneumonia: The aim of this study was to determine if, and which combination of paired blood and bronchoalveolar lavage fluid (BALF) inflammatory biomarkers (soluble and cell surface based, including TREM-1), could correctly classify patients with VAP from ventilated patients without evidence of pulmonary sepsis.